J. L. Blanco

891 total citations
15 papers, 666 citations indexed

About

J. L. Blanco is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, J. L. Blanco has authored 15 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 9 papers in Virology and 3 papers in Epidemiology. Recurrent topics in J. L. Blanco's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (4 papers). J. L. Blanco is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (4 papers). J. L. Blanco collaborates with scholars based in Spain, Croatia and United States. J. L. Blanco's co-authors include José M. Gatell, Vici Varghese, Soo‐Yon Rhee, Robert W. Shafer, Estebán Martínez, Josep Mallolas, Josep M. Gatell, Elisa de Lazzari, Josep‐Maria Peri and Araceli Rousaud and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and The American Journal of Gastroenterology.

In The Last Decade

J. L. Blanco

15 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. L. Blanco Spain	12	451	380	198	139	94	15	666
James Stanford United States	8	955 2.1×	711 1.9×	186 0.9×	286 2.1×	50 0.5×	9	1.1k
Roberta Gagliardini Italy	15	411 0.9×	281 0.7×	120 0.6×	129 0.9×	41 0.4×	65	544
Laurence Slama France	14	303 0.7×	247 0.7×	319 1.6×	105 0.8×	90 1.0×	35	623
Yueming Li Australia	10	398 0.9×	373 1.0×	157 0.8×	224 1.6×	25 0.3×	19	633
Fabienne Caby France	9	232 0.5×	231 0.6×	123 0.6×	92 0.7×	24 0.3×	26	365
Krischan J Hudson United States	11	535 1.2×	358 0.9×	84 0.4×	214 1.5×	114 1.2×	17	698
Laura Bracciale Italy	13	387 0.9×	414 1.1×	188 0.9×	154 1.1×	45 0.5×	21	584
Alessandra Ruggiero Italy	11	321 0.7×	308 0.8×	159 0.8×	142 1.0×	122 1.3×	34	661
Anna Pierce Australia	10	221 0.5×	83 0.2×	71 0.4×	161 1.2×	54 0.6×	27	399
Valerio Tozzi Italy	10	261 0.6×	296 0.8×	128 0.6×	84 0.6×	14 0.1×	21	395

Countries citing papers authored by J. L. Blanco

Since Specialization

Citations

This map shows the geographic impact of J. L. Blanco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. L. Blanco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. L. Blanco more than expected).

Fields of papers citing papers by J. L. Blanco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. L. Blanco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. L. Blanco. The network helps show where J. L. Blanco may publish in the future.

Co-authorship network of co-authors of J. L. Blanco

This figure shows the co-authorship network connecting the top 25 collaborators of J. L. Blanco. A scholar is included among the top collaborators of J. L. Blanco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. L. Blanco. J. L. Blanco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Fustà‐Novell, X., D. Morgado‐Carrasco, Alicia Barreiro, et al.. (2019). Syphilis Maligna: A Presentation to Bear in Mind. Actas Dermo-Sifiliográficas. 110(3). 232–237. 7 indexed citations

2.

Fustà‐Novell, X., D. Morgado‐Carrasco, Alicia Barreiro, et al.. (2018). Sífilis maligna, una presentación de sífilis a tener en cuenta. Actas Dermo-Sifiliográficas. 110(3). 232–237. 9 indexed citations

3.

Ambrosioni, Juan, David Nicolás, Christian Manzardo, et al.. (2016). Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection. Journal of Antimicrobial Chemotherapy. 72(1). 205–209. 16 indexed citations

4.

Martínez‐Rebollar, Maria, Josep Mallolas, Iñaki Pérez, et al.. (2014). Brote epidémico de hepatitis aguda C en pacientes infectados por el virus de la inmunodeficiencia humana. Enfermedades Infecciosas y Microbiología Clínica. 33(1). 3–8. 12 indexed citations

5.

Guardo, Alberto C., María J. Maleno, Marta Calvo, et al.. (2012). In vitro effects of the CCR5 inhibitor maraviroc on human T cell function. Journal of Antimicrobial Chemotherapy. 68(3). 577–586. 33 indexed citations

6.

Blanco, J. L. & Javier Martínez‐Picado. (2012). HIV integrase inhibitors in ART-experienced patients. Current Opinion in HIV and AIDS. 7(5). 415–421. 11 indexed citations

7.

Blanco, J. L., Vici Varghese, Soo‐Yon Rhee, José M. Gatell, & Robert W. Shafer. (2011). HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications. The Journal of Infectious Diseases. 203(9). 1204–1214. 175 indexed citations

8.

Chang, Pik‐Eu, Rosa Miquel, J. L. Blanco, et al.. (2009). Idiopathic Portal Hypertension in Patients With HIV Infection Treated With Highly Active Antiretroviral Therapy. The American Journal of Gastroenterology. 104(7). 1707–1714. 65 indexed citations

9.

García, Felipe, Pedro Castro, J. L. Blanco, et al.. (2005). Risk of Selecting De Novo Drug-Resistance Mutations during Structured Treatment Interruptions in Patients with Chronic HIV Infection. Clinical Infectious Diseases. 41(6). 883–890. 36 indexed citations

10.

Biglia, Alessandro, J. L. Blanco, Estebán Martínez, et al.. (2004). Gynecomastia among HIV-Infected Patients Is Associated with Hypogonadism: A Case-Control Study. Clinical Infectious Diseases. 39(10). 1514–1519. 27 indexed citations

11.

Blanch, Jordi, Araceli Rousaud, Estebán Martínez, et al.. (2002). Impact of Lipodystrophy on the Quality of Life of HIV-1–Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31(4). 404–407. 65 indexed citations

12.

Blanch, Jordi, Estebán Martínez, Araceli Rousaud, et al.. (2001). Preliminary Data of a Prospective Study on Neuropsychiatric Side Effects After Initiation of Efavirenz. JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(4). 336–343. 74 indexed citations

13.

Blanch, Jordi, Estebán Martínez, Araceli Rousaud, et al.. (2001). Preliminary Data of a Prospective Study on Neuropsychiatric Side Effects After Initiation of Efavirenz. JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(4). 336–343. 27 indexed citations

14.

Martínez, Estebán, Miguel A García-Viejo, J. L. Blanco, et al.. (2000). Impact of Switching from Human Immunodeficiency Virus Type 1 Protease Inhibitors to Efavirenz in Successfully Treated Adults with Lipodystrophy. Clinical Infectious Diseases. 31(5). 1266–1273. 108 indexed citations

15.

Barreiro, Pablo, et al.. (1996). [Colonic tuberculosis as a cause of rectal bleeding in 2 patients with HIV infection].. PubMed. 14(9). 538–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact